Cardiovascular revascularization medicine : including molecular interventions
Mid-term outcomes of balloon-expandable vs. self-expanding valves for valve-in-valve TAVR: Insights from the Michigan Structural Heart Consortium.
Ahmad Jabri, Sant Kumar, Amr Abbas, Jonathan X Fang, Luai Madanat, Paul Grossman, Milan Seth, Stanley Chetcuti, Julia Mantey, Rakesh Suri, Alessandro Vivacqua, Thomas Schwann, Simon Dixon, Devraj Sukul, Pedro A Villablanca
Published: 202510.1016/j.carrev.2025.10.005
Abstract
BACKGROUND: Valve-in-valve transcatheter aortic valve replacement (ViV TAVR) is used for degenerated surgical bioprosthetic valves. Comparative outcomes between balloon-expandable valves (BEV) and self-expanding valves (SEV) remain scarce, particular…
Preview only. Read the full abstract at the source